Health-related quality of life with sacituzumab govitecan in HR+/HER2- metastatic breast cancer in the phase III TROPiCS-02 trial

  1. Rugo, H.S.
  2. Schmid, P.
  3. Tolaney, S.M.
  4. Dalenc, F.
  5. Marmé, F.
  6. Shi, L.
  7. Verret, W.
  8. Shah, A.
  9. Gharaibeh, M.
  10. Bardia, A.
  11. Cortes, J.
Revue:
Oncologist

ISSN: 1549-490X,  1083-7159

Année de publication: 2024

Volumen: 29

Número: 9

Pages: 768-779

Type: Article

DOI: 10.1093/ONCOLO/OYAE088 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus